These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 29980054)

  • 21. Clinical profile, genetic spectrum and therapy evaluation of 19 Chinese pediatric patients with lipoprotein lipase deficiency.
    Xia Y; Zheng W; Du T; Gong Z; Liang L; Wang R; Yang Y; Zhang K; Lu D; Chen X; Sun Y; Sun Y; Xiao B; Qiu W
    J Clin Lipidol; 2023; 17(6):808-817. PubMed ID: 37858495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analyses of familial chylomicronemia syndrome in Pereira, Colombia 2010-2020: a cross-sectional study.
    Rodriguez FH; Estrada JM; Quintero HMA; Nogueira JP; Porras-Hurtado GL
    Lipids Health Dis; 2023 Mar; 22(1):43. PubMed ID: 36978188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of lipoprotein lipase activity measurement in the diagnosis of familial chylomicronemia syndrome.
    Rioja J; Ariza MJ; Benítez-Toledo MJ; Espíldora-Hernández J; Coca-Prieto I; Arrobas-Velilla T; Camacho A; Olivecrona G; Sánchez-Chaparro MÁ; Valdivielso P
    J Clin Lipidol; 2023; 17(2):272-280. PubMed ID: 36813655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular analysis of three known and one novel LPL variants in patients with type I hyperlipoproteinemia.
    Caddeo A; Mancina RM; Pirazzi C; Russo C; Sasidharan K; Sandstedt J; Maurotti S; Montalcini T; Pujia A; Leren TP; Romeo S; Pingitore P
    Nutr Metab Cardiovasc Dis; 2018 Feb; 28(2):158-164. PubMed ID: 29288010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Childhood-onset chylomicronaemia with reduced plasma lipoprotein lipase activity and mass: identification of a novel GPIHBP1 mutation.
    Coca-Prieto I; Kroupa O; Gonzalez-Santos P; Magne J; Olivecrona G; Ehrenborg E; Valdivielso P
    J Intern Med; 2011 Sep; 270(3):224-8. PubMed ID: 21314738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Etiology and emerging treatments for familial chylomicronemia syndrome.
    Spagnuolo CM; Hegele RA
    Expert Rev Endocrinol Metab; 2024 Jul; 19(4):299-306. PubMed ID: 38866702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterisation of patients with familial chylomicronaemia syndrome (FCS) and multifactorial chylomicronaemia syndrome (MCS): Establishment of an FCS clinical diagnostic score.
    Moulin P; Dufour R; Averna M; Arca M; Cefalù AB; Noto D; D'Erasmo L; Di Costanzo A; Marçais C; Walther LAA; Banach M; Borén J; Cramb R; Gouni-Berthold I; Hughes E; Johnson C; Pintó X; Reiner Ž; van Lennep JR; Soran H; Stefanutti C; Stroes E; Bruckert E
    Data Brief; 2018 Dec; 21():1334-1336. PubMed ID: 30456254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disappearance of recurrent pancreatitis after splenectomy in familial chylomicronemia syndrome.
    Marco-Benedí V; Lamiquiz-Moneo I; Álvarez-Sala LA; Civeira F
    Atherosclerosis; 2018 Aug; 275():342-345. PubMed ID: 30015297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of chylomicronemia.
    Navarro Hermoso A; Valdivielso P
    Clin Investig Arterioscler; 2021 May; 33 Suppl 2():75-79. PubMed ID: 34006359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Chylomicronemia Syndrome Is Most Often Multifactorial: A Narrative Review of Causes and Treatment.
    Chait A; Eckel RH
    Ann Intern Med; 2019 May; 170(9):626-634. PubMed ID: 31035285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effects of volanesorsen on triglycerides and pancreatitis in patients with familial chylomicronaemia syndrome (FCS) in the UK Early Access to Medicines Scheme (EAMS).
    Jones A; Peers K; Wierzbicki AS; Ramachandran R; Mansfield M; Dawson C; Ochoa-Ferraro A; Soran H; Jenkinson F; McDowell I; Downie P; Hamilton P; Jones RD
    Atherosclerosis; 2023 Jun; 375():67-74. PubMed ID: 37253281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current Diagnosis and Management of Primary Chylomicronemia.
    Okazaki H; Gotoda T; Ogura M; Ishibashi S; Inagaki K; Daida H; Hayashi T; Hori M; Masuda D; Matsuki K; Yokoyama S; Harada-Shiba M
    J Atheroscler Thromb; 2021 Sep; 28(9):883-904. PubMed ID: 33980761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe hypertriglyceridemia: Existing and emerging therapies.
    Malick WA; Do R; Rosenson RS
    Pharmacol Ther; 2023 Nov; 251():108544. PubMed ID: 37848164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Volanesorsen for treatment of familial chylomicronemia syndrome.
    Lazarte J; Hegele RA
    Expert Rev Cardiovasc Ther; 2021 Aug; 19(8):685-693. PubMed ID: 34261380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular basis of the familial chylomicronemia syndrome in patients from the National Dyslipidemia Registry of the Spanish Atherosclerosis Society.
    Ariza MJ; Rioja J; Ibarretxe D; Camacho A; Díaz-Díaz JL; Mangas A; Carbayo-Herencia JA; Ruiz-Ocaña P; Lamíquiz-Moneo I; Mosquera D; Sáenz P; Masana L; Muñiz-Grijalvo O; Pérez-Calahorra S; Valdivielso P;
    J Clin Lipidol; 2018; 12(6):1482-1492.e3. PubMed ID: 30150141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frameshift coding sequence variants in the LPL gene: identification of two novel events and exploration of the genotype-phenotype relationship for variants reported to date.
    Zhang G; Hu Y; Yang Q; Pu N; Li G; Zhang J; Tong Z; Masson E; Cooper DN; Chen JM; Li W
    Lipids Health Dis; 2023 Aug; 22(1):128. PubMed ID: 37568214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chylomicronaemia--current diagnosis and future therapies.
    Brahm AJ; Hegele RA
    Nat Rev Endocrinol; 2015 Jun; 11(6):352-62. PubMed ID: 25732519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Familial lipoprotein lipase deficiency].
    Yoshida T; Gotoda T
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):84-7. PubMed ID: 9645014
    [No Abstract]   [Full Text] [Related]  

  • 39. Characterizing familial chylomicronemia syndrome: Baseline data of the APPROACH study.
    Blom DJ; O'Dea L; Digenio A; Alexander VJ; Karwatowska-Prokopczuk E; Williams KR; Hemphill L; Muñiz-Grijalvo O; Santos RD; Baum S; Witztum JL
    J Clin Lipidol; 2018; 12(5):1234-1243.e5. PubMed ID: 30318066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial chylomicronemia syndrome: case reports of siblings with deletions of the GPIHBP1 gene.
    Kim KY; Heo YJ; Ko JM; Lee YA; Shin CH; Ki CS; Lee YJ
    BMC Endocr Disord; 2024 Apr; 24(1):47. PubMed ID: 38622573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.